Posts With Tag ALNY

Alnylam Pharmaceuticals, Inc. files an 8-K detailing significant corporate changes on February 13, 2025. Essential information for investors and stakeholders.

Explore Alnylam Pharmaceuticals' 8-K filing from January 12, 2025, revealing critical updates impacting investors. Stay informed with key financial insights and corporate changes.